Get startedLog in
    Picture of Newbury Pharmaceuticals AB logo

    NEWBRY — Newbury Pharmaceuticals AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: Newbury Pharmaceuticals Lenalidomide Approved By The Swedish Health Authorities

    Picture of Newbury Pharmaceuticals AB logoNewbury Pharmaceuticals AB
    07/03/2022 08:32
    March 7 (Reuters) - Newbury Pharmaceuticals AB  NEWBRY.ST :
    * LENALIDOMIDE NEWBURY APPROVED BY THE SWEDISH HEALTH
AUTHORITIES
    * MARKETING AUTHORIZATION OF LENALIDOMIDE NEWBURY IN SWEDEN
AS
FIRST COUNTRY IN A SCANDINAVIAN REGISTRATION PROCEDURE
    * APPROVALS IN DENMARK AND NORWAY ARE EXPECTED TO FOLLOW
UPON
FINALIZED NATIONAL REVIEWS.

Source text for Eikon:  ID:nMFN7cY5J4 
Further company coverage:  NEWBRY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Newbury Pharmaceuticals AB

    See all news